Clinical Trial Update: Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial of LTC004 for unresectable or metastatic sarcoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• LTC004 (LTC004)

Snippet

Sponsor: Letolab | Conditions: Unresectable or Metastatic Sarcoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING